In a groundbreaking discussion, Professor Nicolaus Kroger delves into the evolving landscape of allogeneic stem cell transplantation for myelofibrosis. Learn how post-transplant monitoring and strategic donor T cell activity enhancements are critical in maximizing curative outcomes for patients. With years of experience, Professor Kroger highlights the importance of reduced-intensity conditioning and post-transplant interventions in minimizing relapse risks.
Watch the full interview to explore how these approaches are transforming the future of myelofibrosis care!
